In-depth | How much does our HIV response depend on US funding?

Posted in: Access to Medicines, Focus, Healthcare system, Healthcare Workers, HIV/AIDS, InFocus, Latest, Spotlight

After the US slashed global aid, the South African government stated that only 17% of its HIV spending relied on US funding. But some experts argue that US health initiatives had more bang for buck than the government’s programmes. Jesse Copelyn looks past the 17% figure, and considers how the health system is being affected by the loss of US money.

In-depth | How much does our HIV response depend on US funding?

Why people stop taking their HIV treatment and what we can do about it

Posted in: Access to Medicines, Comment, Focus, Healthcare system, HIV/AIDS, InFocus, Latest, Spotlight

Stopping antiretroviral treatment when you are living with HIV can result in increased HIV transmission, illness, hospitalisation, and eventually death. To combat such disengagement with HIV treatment, Professor Graeme Meintjes and colleagues argue we need smarter differentiated care and better education of healthcare workers, people living with HIV, and communities.